Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Y Finlay

Showing results (191-200 of 232) with videos related to

Pageof 24
Sort By:
Journal of Patient-Reported Outcomes|March 26, 2024
Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16)R Shah, A Y Finlay, M S Salek, et al.
European Journal of Haematology|April 5, 2024
Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross-sectional studyR Shah, A Y Finlay, F M Ali, et al.
Diabetes Care|May 1, 1990
Increased collagen-linked fluorescence in skin of young patients with type I diabetes mellitusM H Dominiczak, J Bell, N H Cox, et al.
The British Journal of Dermatology|February 17, 1999
Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of lifeE Grosshans, R Marks, J M Mascaro, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 19, 2013
Chronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicineZ U Bhatti, A Y Finlay, C E Bolton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 23, 2020
Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented OutcomesA Y Finlay, P V Chernyshov, L Tomas Aragones, et al.
The British Journal of Dermatology|June 16, 2006
Update on the use of ciclosporin in immune-mediated dermatosesC E M Griffiths, A Katsambas, B A C Dijkmans, et al.
The British Journal of Dermatology|September 12, 2015
Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 yearsM J van Geel, M Maatkamp, A M Oostveen, et al.
The British Journal of Dermatology|October 20, 2019
Secukinumab for patients failing previous tumour necrosis factor-α inhibitor therapy: results of a randomized open-label study (SIGNATURE)R B Warren, J N W B Barker, A Y Finlay, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 20, 2022
Impact of childhood atopic dermatitis on life decisions for caregivers and familiesK Capozza, A Schwartz, J E Lang, et al.
Pageof 24

Showing results (191-200 of 232) with videos related to

Sort By:
Pageof 24
Journal of Patient-Reported Outcomes|March 26, 2024
Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16)R Shah, A Y Finlay, M S Salek, et al.
European Journal of Haematology|April 5, 2024
Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross-sectional studyR Shah, A Y Finlay, F M Ali, et al.
Diabetes Care|May 1, 1990
Increased collagen-linked fluorescence in skin of young patients with type I diabetes mellitusM H Dominiczak, J Bell, N H Cox, et al.
The British Journal of Dermatology|February 17, 1999
Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of lifeE Grosshans, R Marks, J M Mascaro, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 19, 2013
Chronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicineZ U Bhatti, A Y Finlay, C E Bolton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 23, 2020
Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented OutcomesA Y Finlay, P V Chernyshov, L Tomas Aragones, et al.
The British Journal of Dermatology|June 16, 2006
Update on the use of ciclosporin in immune-mediated dermatosesC E M Griffiths, A Katsambas, B A C Dijkmans, et al.
The British Journal of Dermatology|September 12, 2015
Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 yearsM J van Geel, M Maatkamp, A M Oostveen, et al.
The British Journal of Dermatology|October 20, 2019
Secukinumab for patients failing previous tumour necrosis factor-α inhibitor therapy: results of a randomized open-label study (SIGNATURE)R B Warren, J N W B Barker, A Y Finlay, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 20, 2022
Impact of childhood atopic dermatitis on life decisions for caregivers and familiesK Capozza, A Schwartz, J E Lang, et al.
Pageof 24